Diligence Watchlist A live database of the situations we're tracking across public and private markets — ahead of client demand. Each entry sets out the company, why it's interesting, the questions we'd test, and the experts we'd put on it. Built for the hedge funds and private equity firms that move first.
Rentokil Initial is the global leader in pest control and, through Terminix, one of the two dominant operators in North America. The market view is straightforward: a defensive, recurring-revenue business consolidating a fragmented industry, with a clear path to a North American operating margin above 20% by 2027 once the Terminix integration is finished. That target rests on operational assumptions only primary research can test — whether the branch reorganisation lifts route density, whether technicians and customers stay through the disruption, and whether the termite-claims liability is contained. Here's how we'd test them.
The situation
Rentokil acquired Terminix at the end of 2022 for close to $7bn, making North America roughly 60% of a group that turned over $6.9bn in 2025 and the source of most of its profit. The model runs on dense local route networks: technicians servicing customers on fixed schedules, where short distances between stops cut travel time, raise visits per day and dilute fixed cost. Bolt-on acquisitions are meant to thicken those routes — the group bought 36 businesses in 2025 alone. Margin is a direct function of how tightly the network is packed, and the 2027 target of a North American margin above 20% depends on it, from a 2025 base of 17.4%.
The fragility sits in the integration and what it has exposed. North American pest control organic growth ran at just 0.1% in the first half of 2025 before recovering to 2.6% by the fourth quarter — a turnaround the market rewarded, but one built on pricing as much as volume, against a competitor growing organically at more than 7%. The branch plan has been rewritten more than once; the current end state is around 800 branches and roughly 30 retained brands, a simplification of an earlier and more aggressive consolidation. And the company is carrying a termite-damage claims problem: it took a further $201m of provisions across 2025, settled around $95m in cash, and closed the year with a $384m provision and a warning that 2026 cash outflow would be similar. The reported margin tells you the network was efficient last quarter. It does not tell you the integration ends where management says, or what the claims tail finally costs.
The diligence thesis
The market is pricing the 2027 margin target as if completion were a scheduling question rather than an operational one. A fund taking the other side needs to get one thing right: whether the remaining integration and the legacy liabilities create more drag than the recovering headline growth implies. The conditions that have to hold are specific. Colleague retention, which reached the low 80s in percentage terms, has to keep rising as branches and routes are reorganised rather than reverse. Customer retention, sitting around 81%, has to survive territory changes that put a new technician on a familiar account. Recent growth has to prove volume-led and durable, not a pricing pulse that fades as rivals undercut. And the termite-claims provision has to be adequate rather than the first instalment of a larger number.
None of those conditions is visible in a filing until after it has moved the numbers. Retention prints quarterly, in arrears, blended across the whole base. Technician turnover at a specific reorganising branch never prints at all. The adequacy of a claims reserve is an estimate until claims actually settle. The financials describe the symptom — organic growth that ran below the company's own ambition for most of 2025, and a margin still well short of target. The cause lives in the operations: in the branches being reorganised this quarter, in the technicians deciding whether to stay, in the customers deciding whether to renew, and in the homes filing termite claims.
The primary research questions that matter
- Technician retention through reorganisation. As branches and routes are reshaped toward the ~800-branch end state, what share of technicians leave within the following two quarters, and where do they go? Blended retention disclosure hides the attrition that happens precisely at the pinch point.
- Route density, actually measured. Are stops-per-day and drive-time genuinely improving in reorganised territories, or is the network simply being relabelled? Density is the entire margin mechanism, and it is observable to people who run routes, not to anyone reading a filing.
- Pricing versus volume in the recovery. The North American turnaround leaned heavily on price. Is the late-2025 acceleration holding on volume into 2026, or are customers beginning to resist further increases as independents compete on price?
- Commercial contract renewal under disruption. Do multi-year commercial accounts renew when their technician and service protocol change mid-contract? Buyers, not the company, know whether a reshuffled account is a churn risk or a non-event.
- The termite-claims tail. Is the closing provision sized to the real claims experience, or is the cash outflow likely to persist beyond 2026? People who handle termite remediation and claims in the affected regions see the frequency and severity before it reaches a reserve.
Why this can't be answered from the filings
Filings and models tell you what has been reported, not whether the operational reality holds up. The 2027 margin bridge is a forecast built on integration milestones and a claims reserve that is itself an estimate, and the only people who know whether those are real are the ones living them: technicians who have left reorganised branches, the competitors recruiting them, the commercial buyers deciding whether to renew, the independents acquiring routes in the same metros, and the contractors handling termite claims. Primary research is the method that reaches them — expert calls, channel checks and structured surveys that turn a margin-bridge question into first-hand answers about whether the network is getting denser or just getting bigger, and whether the claims problem is contained or compounding.
The experts we've recruited
- Former Terminix and Rentokil branch and regional operations leaders. People who ran branches through the migration and have since left — they can speak to how routes were redrawn, what broke, and how technician and customer retention behaved at the branch level.
- Operations and retention executives at competing residential operators. Senior operators at independent pest-control firms running the same route-density playbook in the same metros, able to benchmark technician attrition and churn against what they observe locally.
- Commercial facilities and procurement buyers. Facilities directors and vendor managers at large property-services and corporate-real-estate platforms who hold and renew commercial pest contracts and decide whether a disrupted account stays.
- Independent and regional pest-control owner-operators. Owners acquiring routes and hiring technicians in the same territories, positioned to say which accounts and crews are moving during the transition.
- Former field technicians from integrated branches. Frontline staff who experienced the rerouting and pay-model harmonisation first-hand — the most direct read on whether the integration retains or sheds the people the margin depends on.
Commission this research
Woozle Research runs done-for-you primary research for hedge funds and private equity firms — expert calls, surveys and channel checks, delivered as finished intelligence rather than raw notes. For Rentokil the experts are recruited and the questionnaire is ready; we move fast. Commission us to run this primary research for you — or build your own variant of the thesis — and request a quote.
